市場調査レポート

商品コード

1593517

ビタミンK2の市場規模・シェア・成長分析 (機能別、製品種類別、形状別、原料別、用途別、地域別)：産業予測 (2024～2031年)

Vitamin K2 Market Size, Share, Growth Analysis, By Function (Bone and Cardiovascular Health, Blood Health and Clotting), By Product Type (MK-4, MK-7), By Form, By Source, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年11月11日
発行: SkyQuest
ページ情報: 英文 160 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のビタミンK2の市場規模は、2022年に1億4,200万米ドルと評価され、2023年の1億6,174万米ドルから2031年には4億5,814万米ドルに拡大し、予測期間 (2024～2031年) に13.90%のCAGRで成長する見通しです。

ビタミンK2市場は、健康効果に関する消費者の意識の高まり、高齢化、機能性食品への嗜好の高まりなど、いくつかの重要な要因によって大きく成長する態勢を整えています。このサプリメントは、心臓血管の健康、骨の完全性、全体的な健康にプラスの影響を与えることがますます認識されるようになっています。消費者が病気の治療から予防的な健康対策に重点を移すにつれて、ビタミンK2サプリメントの需要は増加すると予想されます。2023年4月、革新的な医療製品で知られるロシアのバイオテクノロジー分野のリーダーPetrovax Pharmは、免疫機能を高めながら筋肉、骨、関節の健康をサポートするよう設計された複合製剤SunDevitを発売しました。この製品は、ビタミンK2とD3を独自に組み合わせたもので、国際的な骨粗鬆症・心血管疾患の増加に伴う健康懸念の高まりに対応しています。ビタミンK2は、カルシウムを骨に誘導する重要な役割を果たし、骨折のリスクを軽減する可能性があります。人口の高齢化と関連する健康状態の発生率の上昇に伴い、効果的なビタミンK2ソリューションへの関心と需要は増加傾向にあり、この分野の市場成長の大きな機会となっています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (MEA)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア (2023年)

主要企業プロファイル

AlloSource (米国)
Smith+Nephew (英国)
Medtronic (アイルランド)
Orthofix US LLC (米国)
Zimmer Biomet (米国)
Geistlich Pharma AG (スイス)
Stryker (米国)
Biobank (英国)
DSM Nutritional Products (スイス)
Pharmavit (インド)
Viridis BioPharma Pvt. Ltd. (インド)
Lactonova Nutripharm Pvt. Ltd. (インド)
Gencor Pacific Inc. (米国)
NuScience Trading, LLC (米国)
NutriScience Innovations LLC (米国)
ExcelVite Sdn. Bhd. (マレーシア)
Parchem Fine & Specialty Chemicals (米国)
Avanscure Lifesciences Pvt. Ltd. (インド)
Health Thru Nutrition (米国)
Ampak Company, Inc. (米国)
Arnet Pharmaceutical (米国)
Swanson Health Products (米国)
AIDP, Inc. (米国)
Ortho Molecular Products (米国)
Evesa Nutritionals (インド)

Product Code: SQMIG35I2355

Global Vitamin K2 Market size was valued at USD 142 million in 2022 and is poised to grow from USD 161.74 million in 2023 to USD 458.14 million by 2031, growing at a CAGR of 13.90% during the forecast period (2024-2031).

The vitamin K2 market is poised for significant growth driven by several key factors, including heightened consumer awareness regarding its health benefits, an aging demographic, and a growing preference for functional foods. This supplement is increasingly recognized for its positive influence on cardiovascular health, bone integrity, and overall wellness. As consumers shift their focus from treating illnesses to preventative health measures, the demand for vitamin K2 supplements is expected to rise. In April 2023, Petrovax Pharm, a leader in the Russian biotech sector known for its innovative medical products, launched SunDevit, a complex formulation designed to support muscle, bone, and joint health while enhancing immune function. This product uniquely combines vitamins K2 and D3, catering to the increasing health concerns associated with the rising prevalence of osteoporosis and cardiovascular diseases globally. Vitamin K2 plays a crucial role in directing calcium to bones, potentially reducing fracture risks, and has been linked to lower incidences of cardiac issues and arterial calcification as demonstrated by various studies. With the aging population and the higher occurrence rates of related health conditions, interest and demand for effective vitamin K2 solutions are on the upswing, marking a significant opportunity for market growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vitamin K2 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vitamin K2 Market Segmental Analysis

Global Vitamin K2 Market is segmented by Function, Product Type, Form, Source, Application, and region. Based on Function, the market is segmented into Bone and Cardiovascular Health, Blood Health and Clotting, and Anti-Inflammatory and Immunity, Other Functions. Based on Product Type, the market is segmented into MK-4, and MK-7. Based on Form, the market is segmented into Capsules & Tablets, Powder and Crystalline, Liquids, and Others. Based on Source, the market is segmented into Natural, and Synthetic. Based on Application, the market is segmented into Pharmaceuticals, Functional Foods and Beverages, Health Supplements. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Vitamin K2 Market

Increased awareness of bone health is a significant market driver for the global Vitamin K2 market. As healthcare professionals and consumers alike recognize the critical role that Vitamin K2 plays in calcium metabolism and bone density, the demand for this essential nutrient has surged. Educational initiatives and campaigns highlighting the importance of maintaining strong bones, particularly among aging populations, athletes, and those with specific dietary restrictions, have further fueled interest in Vitamin K2 supplements. This growing focus on preventative health measures and the promotion of wellness is steering consumers toward fortified food products and dietary supplements containing Vitamin K2, thereby propelling market growth.

Restraints in the Global Vitamin K2 Market

One significant market restraint for the global Vitamin K2 market is the high cost associated with premium supplements. As consumer awareness of health and wellness continues to grow, many individuals seek high-quality Vitamin K2 products, which often come with a steep price tag. This financial barrier can limit accessibility for a broader demographic, particularly in emerging markets where disposable incomes may be lower. Additionally, the perception that high cost equates to superior efficacy may not always hold true, leading to skepticism among potential buyers. Consequently, this dynamic can hinder market growth and reduce overall consumer uptake of Vitamin K2 supplements.

Market Trends of the Global Vitamin K2 Market

The global Vitamin K2 market is witnessing notable growth driven by a rising consumer demand for functional foods. As individuals increasingly seek meals that offer enhanced health benefits beyond basic nutrition, manufacturers are responding by incorporating Vitamin K2 into a diverse range of products, including plant-based alternatives, protein bars, and fortified dairy items. This trend aligns with the broader wellness movement, which emphasizes preventive health and nutrition-focused lifestyles. Consequently, Vitamin K2 is becoming more prevalent and accessible, catering to health-conscious consumers. This market surge not only reflects changing dietary preferences but also signifies an expansion in the functional food sector, further propelling Vitamin K2's popularity.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Case Study Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Technology Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Vitamin K2 Market by Function

Market Overview
Bone And Cardiovascular Health
Blood Health And Clotting
Anti-Inflammatory And Immunity
Other Functions

Vitamin K2 Market by Product Type

Market Overview
MK-4
MK-7

Vitamin K2 Market by Form

Market Overview
Capsules And Tablets
Powder And Crystalline
Liquids
Others

Vitamin K2 Market by Source

Market Overview
Natural
Synthetic

Vitamin K2 Market by Application

Market Overview
Pharmaceuticals
Functional Foods and Beverages
Health Supplements

Vitamin K2 Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith + Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix US LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geistlich Pharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biobank (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSM Nutritional Products (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmavit (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viridis BioPharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lactonova Nutripharm Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gencor Pacific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuScience Trading, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NutriScience Innovations LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ExcelVite Sdn. Bhd. (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parchem Fine & Specialty Chemicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanscure Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Thru Nutrition (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ampak Company, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arnet Pharmaceutical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swanson Health Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AIDP, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Molecular Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evesa Nutritionals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ビタミンK2の市場規模・シェア・成長分析 (機能別、製品種類別、形状別、原料別、用途別、地域別)：産業予測 (2024～2031年)

Vitamin K2 Market Size, Share, Growth Analysis, By Function (Bone and Cardiovascular Health, Blood Health and Clotting), By Product Type (MK-4, MK-7), By Form, By Source, By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ビタミンK2市場：機能別

ビタミンK2市場：製品種類別

ビタミンK2市場：形状別

ビタミンK2市場：原料別

ビタミンK2市場：用途別

ビタミンK2市場：地域別